UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Omeros Corp (OMER)

Omeros Corp (OMER)
6.00 x 20 6.90 x 10
Post-market by (Cboe BZX)
6.78 +0.02 (+0.30%) 04/17/25 [NASDAQ]
6.00 x 20 6.90 x 10
Post-market 6.78 unch (unch) 16:07 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
6.56
Day High
6.88
Open 6.79
Previous Close 6.76 6.76
Volume 423,300 423,300
Avg Vol 917,440 917,440
Stochastic %K 33.14% 33.14%
Weighted Alpha +16.73 +16.73
5-Day Change +0.92 (+15.70%) +0.92 (+15.70%)
52-Week Range 2.96 - 13.60 2.96 - 13.60
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 393,674
  • Shares Outstanding, K 58,064
  • Annual Sales, $ 0 K
  • Annual Income, $ -156,820 K
  • EBIT $ -169 M
  • EBITDA $ -167 M
  • 60-Month Beta 2.35
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 85.70% ( +6.46%)
  • Historical Volatility 92.40%
  • IV Percentile 35%
  • IV Rank 43.04%
  • IV High 178.78% on 05/16/24
  • IV Low 15.36% on 06/07/24
  • Put/Call Vol Ratio 1.12
  • Today's Volume 276
  • Volume Avg (30-Day) 709
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 31,506
  • Open Int (30-Day) 27,695

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.74
  • Growth Rate Est. (year over year) +135,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.64 +20.32%
on 04/09/25
Period Open: 8.52
9.39 -27.80%
on 03/21/25
-1.74 (-20.42%)
since 03/17/25
3-Month
5.64 +20.32%
on 04/09/25
Period Open: 9.33
10.03 -32.40%
on 02/21/25
-2.55 (-27.33%)
since 01/17/25
52-Week
2.96 +128.67%
on 04/25/24
Period Open: 3.34
13.60 -50.15%
on 12/19/24
+3.44 (+102.99%)
since 04/17/24

Most Recent Stories

More News
Omeros: Q4 Earnings Snapshot

Omeros: Q4 Earnings Snapshot

OMER : 6.78 (+0.30%)
Omeros: Q3 Earnings Snapshot

Omeros: Q3 Earnings Snapshot

OMER : 6.78 (+0.30%)
Omeros: Q2 Earnings Snapshot

Omeros: Q2 Earnings Snapshot

OMER : 6.78 (+0.30%)
Omeros: Q1 Earnings Snapshot

Omeros: Q1 Earnings Snapshot

OMER : 6.78 (+0.30%)
Omeros: Q4 Earnings Snapshot

Omeros: Q4 Earnings Snapshot

OMER : 6.78 (+0.30%)
Omeros: Q3 Earnings Snapshot

Omeros: Q3 Earnings Snapshot

OMER : 6.78 (+0.30%)
Omeros: Q2 Earnings Snapshot

Omeros: Q2 Earnings Snapshot

OMER : 6.78 (+0.30%)
Why Shares of Omeros Dropped on Monday

The clinical-stage biopharmaceutical released trials data through a presentation.

OMER : 6.78 (+0.30%)
Omeros: Q1 Earnings Snapshot

Omeros: Q1 Earnings Snapshot

OMER : 6.78 (+0.30%)
Omeros Corporation to Announce First Quarter Financial Results on May 9, 2023

Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its first quarter financial results for the period ended March 31, 2023, on Tuesday, May 9, 2023, after the market closes....

OMER : 6.78 (+0.30%)

Business Summary

Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM)...

See More

Key Turning Points

3rd Resistance Point 7.23
2nd Resistance Point 7.05
1st Resistance Point 6.92
Last Price 6.78
1st Support Level 6.60
2nd Support Level 6.42
3rd Support Level 6.29

See More

52-Week High 13.60
Fibonacci 61.8% 9.54
Fibonacci 50% 8.28
Fibonacci 38.2% 7.03
Last Price 6.78
52-Week Low 2.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro